Filter
529
Filtered Results: 529
Text search:
molecular
markers
Featured
Recommendations
68
New Publications
104
Language
Document type
No document type
242
Guidelines
112
Studies & Reports
98
Manuals
36
Strategic & Response Plan
18
Fact sheets
10
Training Material
7
Situation Updates
5
Resource Platforms
1
Countries / Regions
India
43
Global
23
Africa
14
Latin America and the Carribbean
13
Kenya
12
Tanzania
12
Western and Central Europe
12
Ethiopia
8
Eastern Europe
8
South Africa
7
South–East Asia Region
6
Philippines
5
East and Southern Africa
5
West and Central Africa
5
Sierra Leone
4
Nigeria
4
Uganda
4
Zimbabwe
4
Indonesia
4
Western Pacific Region
4
Asia
4
Cameroon
3
Nepal
3
Pakistan
3
Malawi
3
Brazil
3
Myanmar / Burma
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
USA
2
Zambia
2
Syria
2
Benin
2
Ukraine
2
Middle East and North Africa
2
Venezuela
2
North America
2
Burkina Faso
1
Senegal
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Somalia
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Cambodia
1
Thailand
1
China
1
Rwanda
1
Malaysia
1
Bangladesh
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Angola
1
Lesotho
1
Eastern Europe and Central Asia
1
Timor Leste/ East Timor
1
Georgia
1
Vietnam
1
Japan
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
136
Clinical Guidelines
97
Public Health
38
Pharmacy & Technologies
24
Key Resources
14
Women & Child Health
12
Capacity Building
4
Toolboxes
TB
75
COVID-19
56
AMR
48
HIV
36
NTDs
31
Rapid Response
29
Mental Health
28
Planetary Health
17
NCDs
14
Ebola
10
Refugee
8
Pharmacy
8
Polio
5
Zika
5
Specific Hazards
4
Cholera
3
Conflict
3
Global Health Education
3
Caregiver
3
Disability
2
Natural Hazards
2
Health Financing Toolbox
1
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ...
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of...
interim guidance, 25 November 2024
SAGE-Hindawi Access to Research Autoimmune Diseases
Volume 2011, Article ID 937586, 5 pages doi:10.4061/2011/937586
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
AHA/ASA Guideline
DOI: 10.1161/STR.0000000000000158
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
Accessed Febr.6, 2020
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Action Plan 2021-2025
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
